California Statutes
§ 125291.120. — 125291.120. (Added November 3, 2020, by initiative Proposition 14, Sec. 24.)
California·Code HSC Health and Safety Code - HSC·Div. 106. DIVISION 106. PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)·Part 5. PART 5. HEREDITARY DISEASES/CONGENITAL DEFECTS·Ch. 3. CHAPTER 3. California Stem Cell Research and Cures Bond Act·Art. 2.5. ARTICLE 2.5. California Stem Cell Research, Treatments, and Cures Bond Act of 2020
(a)Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law (Chapter 4 (commencing with Section 16720) of Part 3 of Division 4 of Title 2 of the Government Code), of the bonds and interim debt authorized by this article, the California Stem Cell Research and Cures Finance Committee, established pursuant to Section 125291.40, is hereby designated as “the committee” as that term is used in the State General Obligation Bond Law.
(b)For purposes of the State General Obligation Bond Law, the California Institute for Regenerative Medicine Governing Board is designated the “board.”
Free access — add to your briefcase to read the full text and ask questions with AI
California § 125291.120. (125291.120. (Added November 3, 2020, by initiative Proposition 14, Sec. 24.)) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
Added November 3, 2020, by initiative Proposition 14, Sec. 24. Effective on December 16, 2020.